ABOUT CONOLIDINE

These final results, together with a past report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the idea of focusing on ACKR3 as a novel strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-relevant Diseases.It can even be legally marketed to all athletes